Association of Selective Serotonin Reuptake Inhibitor Use After Intracerebral Hemorrhage With Hemorrhage Recurrence and Depression Severity
Open Access
- 31 August 2020
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 78 (1) , 61-67
Abstract
Importance Selective serotonin reuptake inhibitors (SSRIs) are widely used to treat poststroke depression but are associated with increased incidence of first-ever intracerebral hemorrhage (ICH) in the general population. The decision to treat ICH survivors with SSRIs must therefore balance potential risks of ICH recurrence with presumed benefits on depressive symptoms. Objective To determine whether SSRI use among survivors of primary ICH was associated with ICH recurrence and decreased severity of depressive symptoms. Design, Setting, and Participants Longitudinal ICH cohort study at a tertiary care center enrolling from January 2006 to December 2017, with follow-up for a median of 53.2 months (interquartile range, 42.3-61.2 months). The study included 1279 consenting individuals (1049 White, 89 Black, 77 Hispanic, and 64 other race/ethnicity) of 1335 eligible patients presenting with primary ICH and who were discharged alive from initial hospitalization for stroke. Main Outcomes and Measures We conducted univariable and multivariable analyses for ICH recurrence risk and depression severity, including subset analyses for patients with 1 or more of the following characteristics associated with high ICH recurrence risk: (1) lobar ICH; (2) presence of the apolipoprotein ε2/ε4 gene variants; (3) prior history of ICH/TIA/ischemic stroke; and (4) Black or Hispanic race/ethnicity. Results Mean age of study participants was 71.3 years, with 602 women (47%); of the 1279 participants, 1049 were White, 89 were Black, 77 were Hispanic, and 64 were other race/ethnicity. SSRI exposure was associated with both ICH recurrence (subhazard ratio [SHR], 1.31; 95% CI, 1.08-1.59) and resolution of post-ICH depression (SHR, 1.53; 95% CI, 1.12 2.09). Among those individuals at high risk for recurrent ICH, SSRIs were associated with further elevation in risk for ICH recurrence (SHR, 1.79; 95% CI, 1.22-2.64) compared with all other survivors of ICH (SHR, 1.20; 95% CI, 1.01-1.42;P = .008 for comparison of effect sizes). The association of SSRI with reduced depressive symptoms did not differ between high those at high risk for recurrent ICH and all other ICH survivors. Conclusions and Relevance Selective serotonin reuptake inhibitor exposure after ICH is associated with both improvement in depressive symptoms and increased risk of recurrent hemorrhagic stroke. Clinical history, neuroimaging data, and genetic biomarkers may help to identify survivors of ICH more likely to safely tolerate SSRI use.Keywords
This publication has 26 references indexed in Scilit:
- Association Between Blood Pressure Control and Risk of Recurrent Intracerebral HemorrhageJAMA, 2015
- Performance of time-dependent propensity scores: a pharmacoepidemiology case studyPharmacoepidemiology and Drug Safety, 2014
- Depression and dementia: Cause, consequence or coincidence?Maturitas, 2014
- Part I: Frequency of Depression after Stroke: An Updated Systematic Review and Meta-Analysis of Observational StudiesInternational Journal of Stroke, 2014
- Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysisJournal of Neurology, Neurosurgery & Psychiatry, 2013
- One‐to‐many propensity score matching in cohort studiesPharmacoepidemiology and Drug Safety, 2012
- Variants at APOE influence risk of deep and lobar intracerebral hemorrhageAnnals of Neurology, 2010
- Comparison of Methods for Estimating the Number of True Null Hypotheses in Multiplicity TestingJournal of Biopharmaceutical Statistics, 2003
- Assessing Self‐maintenance: Activities of Daily Living, Mobility, and Instrumental Activities of Daily LivingJournal of the American Geriatrics Society, 1983
- Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily LivingThe Gerontologist, 1969